Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SEQUENTIAL CHEMOIMMUNOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Moretti, S; Carli, P; Biggeri, A; Volpi, V; Pimpinelli, N
      Cohort study of metastatic melanoma patients in the Dermatology Institute of Florence 1990/1997

      JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
    2. O'Day, SJ; Boasberg, PD; Kristedja, TS; Martin, M; Wang, HJ; Fournier, P; Cabot, M; DeGregorio, MW; Gammon, G
      High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma

      CANCER
    3. Dillman, RO; Soori, G; Wiemann, MC; Schulof, R; Dobbs, TW; Ruben, RH; DePriest, CB; Church, C
      Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: Final results of Cancer Biotherapy Research Group94-11

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    4. de Gast, GC; Klumpen, HJ; Vyth-Dreese, FA; Kersten, MJ; Verra, NCV; Sein, J; Batchelor, D; Nooijen, WJ; Schornagel, JH
      Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma

      CLINICAL CANCER RESEARCH
    5. Kubo, H; Matsumoto, K; Funahashi, M; Takagi, H; Kitajima, Y; Taniguchi, S; Saida, T
      Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice

      MELANOMA RESEARCH
    6. Bernengo, MG; Quaglino, P; Cappello, N; Lisa, F; Osella-Abate, S; Fierro, MT
      Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients

      MELANOMA RESEARCH
    7. Schmidt, H; Geertsen, PF; Fode, K; Rytter, C; Bastholt, L; von der Maase, H
      Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study

      MELANOMA RESEARCH
    8. Vaughan, MM; Moore, J; Riches, PG; Johnston, SRD; A'Hern, RP; Hill, ME; Eisen, T; Ayliffe, MJ; Thomas, JM; Gore, ME
      GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma

      ANNALS OF ONCOLOGY
    9. Baekke, J; Rytter, C; Mouridsen, H; Madsen, EL; Moholt, K; Bastholt, L
      A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanoma

      ACTA ONCOLOGICA
    10. Keilholz, U; Eggermont, AMM
      The emerging role of cytokines in the treatment of advanced melanoma

      ONCOLOGY
    11. Le Cesne, A; Vassal, G; Farace, F; Spielmann, M; Le Chevalier, T; Angevin, E; Valteau-Couanet, D; Fizazi, K; Cojean, I; Llombard, A; Tursz, T; Escudier, B
      Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?

      JOURNAL OF IMMUNOTHERAPY
    12. Naglieri, E; Procacci, A; Galetta, D; Abbate, I; Dell'Erba, L; Colucci, G
      Cisplatin, interleukin-2, interferon-alpha and tamoxifen in metastatic melanoma. A phase II study

      JOURNAL OF CHEMOTHERAPY
    13. O'Day, SJ; Gammon, G; Boasberg, PD; Martin, MA; Kristedja, TS; Guo, M; Stern, S; Edwards, S; Fournier, P; Weisberg, M; Cannon, M; Fawzy, NW; Johnson, TD; Essner, R; Foshag, LJ; Morton, DL
      Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    14. Richards, JM; Gale, D; Mehta, N; Lestingi, T
      Combination of chemotherapy with interleukin-2 and interferon alfa for thetreatment of metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    15. Margolin, KA; Liu, PY; Unger, JM; Fletcher, WS; Flaherty, LE; Urba, WJ; Hersh, EM; Hutchins, LE; Sosman, JA; Smith, JW; Weiss, GR; Sondak, VK
      Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    16. Ollila, DW; Hsueh, EC; Stern, SL; Morton, DL
      Metastasectomy for recurrent stage IV melanoma

      JOURNAL OF SURGICAL ONCOLOGY
    17. Kashani-Sabet, M; Sagebiel, RW; Collins, HE; Glassberg, AB; Allen, RE; Leong, SPL; Small, EJ
      Outpatient combination chemoimmunotherapy for patients with metastatic melanoma - Results of a phase I/II trial

      CANCER
    18. Dorval, T; Negrier, S; Chevreau, C; Avril, MF; Baume, D; Cupissol, D; Oskam, R; de Peuter, R; Vinke, J; Herrera, L; Escudier, B
      Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma

      CANCER
    19. Morton, DL; Ollila, DW; Hsueh, EC; Essner, R; Gupta, RK
      Cytoreductive surgery and adjuvant immunotherapy: A new management paradigm for metastatic melanoma

      CA-A CANCER JOURNAL FOR CLINICIANS
    20. ANDRES P; CUPISSOL D; GUILLOT B; AVRIL MF; DRENO B
      SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA THERAPY ASSOCIATED WITH CISPLATIN MONOCHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA

      EJD. European journal of dermatology
    21. PUNT CJA
      THE USE OF INTERFERON-ALPHA IN THE TREATMENT OF CUTANEOUS MELANOMA - A REVIEW

      Melanoma research
    22. Proebstle, TM; Fuchs, T; Scheibenbogen, C; Sterry, W; Keilholz, U
      Long-term outcome of treatment with dacarbazine, cisplatin, interferon-alpha and intravenous high dose interleukin-2 in poor risk melanoma patients

      MELANOMA RESEARCH
    23. KEILHOLZ U; CONRADT C; LEGHA SS; KHAYAT D; SCHEIBENBOGEN C; THATCHER N; GOEY SH; GORE M; DORVAL T; HANCOCK B; PUNT CJA; DUMMER R; AVRIL MF; BROCKER EB; BENHAMMOUDA A; EGGERMONT AMM; PRITSCH M
      RESULTS OF INTERLEUKIN-2-BASED TREATMENT IN ADVANCED MELANOMA - A CASE RECORD-BASED ANALYSIS OF 631 PATIENTS

      Journal of clinical oncology
    24. LEGHA SS; RING S; ETON O; BEDIKIAN A; BUZAID AC; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT OF A BIOCHEMOTHERAPY REGIMEN WITH CONCURRENT ADMINISTRATION OF CISPLATIN, VINBLASTINE, DACARBAZINE, INTERFERON-ALPHA, AND INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC MELANOMA

      Journal of clinical oncology
    25. MARGOLIN KA; LIU PY; FLAHERTY LE; SOSMAN JA; WALKER MJ; SMITH JW; FLETCHER WS; WEISS GR; UNGER JM; SONDAK VK
      PHASE-II STUDY OF CARMUSTINE, DACARBAZINE, CISPLATIN, AND TAMOXIFEN IN ADVANCED MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    26. RAAD II; HACHEM RY; ABISAID D; ROLSTON KVI; WHIMBEY E; BUZAID AC; LEGHA S
      A PROSPECTIVE CROSSOVER RANDOMIZED TRIAL OF NOVOBIOCIN AND RIFAMPIN PROPHYLAXIS FOR THE PREVENTION OF INTRAVASCULAR CATHETER INFECTIONS IN CANCER-PATIENTS TREATED WITH INTERLEUKIN-2

      Cancer
    27. OLHOFFER IH; BOLOGNIA JL
      WHATS NEW IN THE TREATMENT OF CUTANEOUS MELANOMA

      Seminars in cutaneous medicine and surgery
    28. FRIDMAN WH; TARTOUR E
      THE USE OF CYTOKINES IN THE TREATMENT OF SOLID TUMORS

      HEMATOLOGY AND CELL THERAPY
    29. ARINAGA S; UEO H; GO H; AKIYOSHI T
      NEOADJUVANT CHEMOIMMUNOTHERAPY WITH CISPLATIN AND LOW-DOSE INTERLEUKIN-2 FOR LOCALLY ADVANCED ESOPHAGEAL-CARCINOMA

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    30. LEGHA SS; RING S; ETON O; BEDIKIAN A; PLAGER C; PAPADOPOULOS N
      DEVELOPMENT AND RESULTS OF BIOCHEMOTHERAPY IN METASTATIC MELANOMA - THE UNIVERSITY-OF-TEXAS-M.D.-ANDERSON-CANCER-CENTER EXPERIENCE

      The cancer journal from Scientific American
    31. KEILHOLZ U; STOTER G; PUNT CJA; SCHEIBENBOGEN C; LEJEUNE F; EGGERMONT AMM
      RECOMBINANT INTERLEUKIN-2-BASED TREATMENTS FOR ADVANCED MELANOMA - THE EXPERIENCE OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER MELANOMA COOPERATIVE GROUP

      The cancer journal from Scientific American
    32. THOMPSON JA; GOLD PJ; MARKOWITZ DR; BYRD DR; LINDGREN CG; FEFER A
      UPDATED ANALYSIS OF AN OUTPATIENT CHEMOIMMUNOTHERAPY REGIMEN FOR TREATING METASTATIC MELANOMA

      The cancer journal from Scientific American
    33. LEGHA SS
      THE ROLE OF INTERFERON-ALFA IN THE TREATMENT OF METASTATIC MELANOMA

      Seminars in oncology
    34. LEGHA SS
      DURABLE COMPLETE RESPONSES IN METASTATIC MELANOMA TREATED WITH INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFA AND CHEMOTHERAPY

      Seminars in oncology
    35. THOMPSON JA; GOLD PJ; FEFER A
      OUTPATIENT CHEMOIMMUNOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA

      Seminars in oncology
    36. MORDOH J; KAIRIYAMA C; BOVER L; SOLAROLO E
      ALLOGENEIC CELLS VACCINE INCREASES DISEASE-FREE SURVIVAL IN STAGE-IIIMELANOMA PATIENTS - A NON RANDOMIZED PHASE-II STUDY

      Medicina
    37. PUNT CJA; VANHERPEN CML; JANSEN RLH; VREUGDENHIL G; MULLER EW; DEMULDER PHM
      CHEMOIMMUNOTHERAPY WITH BLEOMYCIN, VINCRISTINE, LOMUSTINE, DACARBAZINE (BOLD) PLUS INTERFERON-ALPHA FOR METASTATIC MELANOMA - A MULTICENTERPHASE-II STUDY

      British Journal of Cancer
    38. GINOPOULOS P; SPIROPOULOS K; ALIVISATOS B; KARDAMAKIS E; TZINGOUNIS VA
      SEQUENTIAL CHEMOIMMUNOTHERAPY TREATMENT OF METASTATIC MALIGNANT-MELANOMA - DIFFERENTIAL RESPONSES BETWEEN LOCOREGIONAL DISEASE AND METASTATIC SITES

      Oncology Reports
    39. PROEBSTLE TM; SCHEIBENBOGEN C; STERRY W; KEILHOLZ U
      A PHASE-II STUDY OF DACARBAZINE, CISPLATIN, INTERFERON-ALPHA AND HIGH-DOSE INTERLEUKIN-2 IN POOR-RISK METASTATIC MELANOMA

      European journal of cancer
    40. LEGHA SS; RING S; BEDIKIAN A; PLAGER C; ETON O; BUZAID AC; PAPADOPOULOS N
      TREATMENT OF METASTATIC MELANOMA WITH COMBINED CHEMOTHERAPY CONTAINING CISPLATIN, VINBLASTINE AND DACARBAZINE (CVD) AND BIOTHERAPY USING INTERLEUKIN-2 AND INTERFERON-ALPHA

      Annals of oncology
    41. VILLIKKA K; PYRHONEN S
      CYTOKINE THERAPY OF MALIGNANT-MELANOMA

      Annals of medicine
    42. BENHAMMOUDA A; AUCLERC G; COEFFIC D; WEIL M; NIZRI D; SOUBRANE C; BANZET P; KHAYAT D
      CHEMOTHERAPY AND IMMUNOTHERAPY FOR DISSEM INATED MALIGNANT MELANOMAS

      La Presse medicale
    43. TARTOUR E; DORVAL T; LEE RS; FRIDMAN WH
      IMMUNOTHERAPY IN THE TREATMENT OF CANCER

      La Presse medicale
    44. OBADINA M; VERMA U; HAWKINS M; MAZUMDER A
      IMMUNOMODULATION FOLLOWING CHEMOTHERAPY

      Breast cancer research and treatment
    45. MCCLAY EF; MCCLAY MET
      SYSTEMIC CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA

      Seminars in oncology
    46. ETON O; TALPAZ M; LEE KH; ROTHBERG JM; BRELL JM; BENJAMIN RS
      PHASE-II TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-2 AND INTERFERON-ALPHA-2A - IMPLICATIONS FOR THE TREATMENT OF PATIENTS WITH METASTATIC MELANOMA

      Cancer
    47. LEGHA SS; GIANAN MA; PLAGER C; ETON OE; PAPADOPOULOUS NEJ
      EVALUATION OF INTERLEUKIN-2 ADMINISTERED BY CONTINUOUS-INFUSION IN PATIENTS WITH METASTATIC MELANOMA

      Cancer
    48. KRUIT WHJ; PUNT CJA; GOEY SH; DEMULDER PHM; GRATAMA JW; EGGERMONT AMM; BOLHUIS RLH; STOTER G
      DOSE EFFICACY STUDY OF 2 SCHEDULES OF HIGH-DOSE BOLUS ADMINISTRATION OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN METASTATIC MELANOMA

      British Journal of Cancer
    49. BARTH A; WANEK LA; MORTON DL
      PROGNOSTIC FACTORS IN 1,521 MELANOMA PATIENTS WITH DISTANT METASTASES

      Journal of the American College of Surgeons
    50. ABBOTT KL; HARMAN GS
      COMBINATION CHEMOTHERAPY FOR DISSEMINATED MALIGNANT-MELANOMA

      Anti-cancer drugs
    51. PROBST M; BUER J; GANSER A; ATZPODIEN J
      INTERLEUKIN-2 IN HEMATOLOGY AND ONCOLOGY - STATE-OF-THE-ART

      The Cancer journal
    52. TILGEN W
      MALIGNANT-MELANOMA - CURRENT THERAPEUTIC CONCEPTS

      Onkologie
    53. ANTOINE EC; RIXE O; VUILLEMIN E; BENHAMMOUDA A; BOREL C; GHIRONZI GC; MULARONI E; FRANKS C; AUCLERC G; SOUBRANE C; BANZET P; WEIL M; KHAYAT D
      A PHASE-II STUDY OF TAMOXIFEN COMBINED WITH CISPLATIN-INTERLEUKIN-2 AND ALPHA-INTERFERON IN METASTATIC MELANOMA

      American journal of clinical oncology
    54. JOHNSON TM; SMITH JW; NELSON BR; CHANG A
      CURRENT THERAPY FOR CUTANEOUS MELANOMA

      Journal of the American Academy of Dermatology
    55. SOSMAN JA; FLAHERTY LE; LIU PY; FLETCHER W; THOMPSON JA; HANTEL A; SONDAK V
      A PHASE-II TRIAL OF PIROXANTRONE IN DISSEMINATED MALIGNANT-MELANOMA -A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    56. HEYWOOD GR; ROSENBERG SA; WEBER JS
      HYPERSENSITIVITY REACTIONS TO CHEMOTHERAPY AGENTS IN PATIENTS RECEIVING CHEMOIMMUNOTHERAPY WITH HIGH-DOSE INTERLEUKIN-2

      Journal of the National Cancer Institute
    57. BUZAID AC; LEGHA SS
      COMBINATION OF CHEMOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA FOR THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 08:36:22